ArticleScientific reports2019

Assessment of Dapagliflozin Effectiveness as Add-on Therapy for the Treatment of Type 2 Diabetes Mellitus in a Qatari Population.

Rana Moustafa Al AdAwi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.